Search

everythinglearnresearchcommunity

for

Search:↓

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

Low power red laser with efavirenz can reduce HIV-1 infection to undetectable levels and improve diagnosis.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

A black-skinned woman was diagnosed with Vogt-Koyanagi-Harada disease and treated with steroids and eye drops.

UC-MSCs derived secretome therapy may help treat hair loss safely.

Treating vitiligo with stem cells and melanocytes from hair, along with UVB light, works better than without the light.

The treatment was not recommended due to limited effectiveness and significant side effects.

New therapies for alopecia areata show potential but need more research.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Early recognition and treatment of VATS in transplant patients improve outcomes.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Avacopan may cause unexpected side effects, so early monitoring is important.

Adding a specific gene to skin cells can help treat skin disorders like psoriasis.

UVFT helps diagnose hair and scalp diseases by showing different fluorescence patterns.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.